USANA Health Sciences, Inc. (NYSE:USNA) Director Gilbert A. Fuller sold 282 shares of the business’s stock in a transaction that occurred on Monday, November 5th. The stock was sold at an average price of $113.54, for a total value of $32,018.28. The sale was disclosed in a filing with the SEC, which is available through this link.

Shares of NYSE USNA opened at $119.56 on Friday. USANA Health Sciences, Inc. has a 1-year low of $64.70 and a 1-year high of $137.95. The company has a market cap of $2.89 billion, a price-to-earnings ratio of 29.45 and a beta of 0.80.

USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings data on Tuesday, October 23rd. The company reported $1.24 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.10 by $0.14. The company had revenue of $296.80 million for the quarter, compared to analysts’ expectations of $289.54 million. USANA Health Sciences had a return on equity of 30.37% and a net margin of 7.57%. The firm’s revenue for the quarter was up 13.4% on a year-over-year basis. During the same period in the previous year, the firm posted $1.03 earnings per share. On average, equities analysts predict that USANA Health Sciences, Inc. will post 4.9 EPS for the current fiscal year.

USANA Health Sciences declared that its board has approved a share repurchase plan on Tuesday, October 23rd that allows the company to buyback $150.00 million in outstanding shares. This buyback authorization allows the company to reacquire up to 5.9% of its shares through open market purchases. Shares buyback plans are typically an indication that the company’s board believes its stock is undervalued.

USNA has been the topic of several analyst reports. Pivotal Research raised USANA Health Sciences from a “hold” rating to a “buy” rating and set a $135.00 price objective on the stock in a research note on Wednesday, October 24th. Sidoti raised USANA Health Sciences from a “neutral” rating to a “buy” rating in a research note on Thursday, October 25th. Finally, ValuEngine cut USANA Health Sciences from a “buy” rating to a “hold” rating in a research note on Thursday.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Metropolitan Life Insurance Co. NY grew its stake in shares of USANA Health Sciences by 16.1% during the second quarter. Metropolitan Life Insurance Co. NY now owns 4,482 shares of the company’s stock valued at $517,000 after buying an additional 623 shares during the last quarter. United Services Automobile Association grew its stake in shares of USANA Health Sciences by 9.9% during the second quarter. United Services Automobile Association now owns 6,972 shares of the company’s stock valued at $804,000 after buying an additional 630 shares during the last quarter. WINTON GROUP Ltd grew its stake in shares of USANA Health Sciences by 9.5% during the second quarter. WINTON GROUP Ltd now owns 8,425 shares of the company’s stock valued at $971,000 after buying an additional 733 shares during the last quarter. State Board of Administration of Florida Retirement System grew its stake in shares of USANA Health Sciences by 30.6% during the second quarter. State Board of Administration of Florida Retirement System now owns 3,582 shares of the company’s stock valued at $413,000 after buying an additional 840 shares during the last quarter. Finally, Harvest Fund Management Co. Ltd grew its stake in shares of USANA Health Sciences by 418.6% during the third quarter. Harvest Fund Management Co. Ltd now owns 1,224 shares of the company’s stock valued at $148,000 after buying an additional 988 shares during the last quarter. 52.20% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: “Insider Selling: USANA Health Sciences, Inc. (USNA) Director Sells $32,018.28 in Stock” was originally reported by Daily Political and is the property of of Daily Political. If you are reading this piece of content on another site, it was stolen and republished in violation of US & international trademark and copyright law. The original version of this piece of content can be viewed at https://www.dailypolitical.com/2018/11/10/insider-selling-usana-health-sciences-inc-usna-director-sells-32018-28-in-stock.html.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition.

Featured Article: What are the most popular ETFs

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.